Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure
Inhibitors of dipeptidyl peptidase-4 (DPP-4) are widely used to treat diabetes mellitus, but data concerning their effects on the barrier stability of retinal endothelial cells (REC) in vivo and in vitro are inconsistent. Therefore, we studied whether the barrier properties of immortalized endotheli...
Saved in:
Main Authors: | Anja Jäckle, Focke Ziemssen, Eva-Maria Kuhn, Jürgen Kampmeier, Gerhard K. Lang, Gabriele E. Lang, Helmut Deissler, Heidrun L. Deissler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2020/2450781 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chorea as the First and Only Manifestation of Systemic Lupus Erythematosus
by: Abdul Razzakh Poil, et al.
Published: (2012-01-01) -
Deciphering the Topology of Sitagliptin Using an Integrated Approach
by: Renny Mathew, et al.
Published: (2025-01-01) -
Sitagliptin: a potential drug for the treatment of COVID-19?
by: Bardaweel Sanaa K., et al.
Published: (2021-06-01) -
Inflation not only driven by energy
by: Klaus-Jürgen Gern, et al.
Published: (2022-05-01) -
Retina and Omega-3
by: Giuseppe Querques, et al.
Published: (2011-01-01)